Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446270
What this trial is testing
Efficacy of Tunlametinib in Combination With Anti-EGFR Monoclonal Antibody in Patients With RAS-Mutated Advanced Gastrointestinal Malignancies
Who this might be right for
Treatment for Advanced Colorectal CancerTreatment for Advanced Pancreatic Cancer
Chinese PLA General Hospital 90